These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
577 related articles for article (PubMed ID: 33024120)
1. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Zhang Y; Gu Y; Ren H; Wang S; Zhong H; Zhao X; Ma J; Gu X; Xue Y; Huang S; Yang J; Chen L; Chen G; Qu S; Liang J; Qin L; Huang Q; Peng Y; Li Q; Wang X; Kong P; Hou G; Gao M; Shi Z; Li X; Qiu Y; Zou Y; Yang H; Wang J; Xu G; Lai S; Li J; Ning G; Wang W Nat Commun; 2020 Oct; 11(1):5015. PubMed ID: 33024120 [TBL] [Abstract][Full Text] [Related]
2. Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study. Wang S; Ren H; Zhong H; Zhao X; Li C; Ma J; Gu X; Xue Y; Huang S; Yang J; Chen L; Chen G; Qu S; Liang J; Qin L; Huang Q; Peng Y; Li Q; Wang X; Zou Y; Shi Z; Li X; Li T; Yang H; Lai S; Xu G; Li J; Zhang Y; Gu Y; Wang W Gut Microbes; 2022; 14(1):2003176. PubMed ID: 34923903 [TBL] [Abstract][Full Text] [Related]
3. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids. Yao Y; Chen H; Yan L; Wang W; Wang D Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study. Ming J; Yu X; Xu X; Wang L; Ding C; Wang Z; Xie X; Li S; Yang W; Luo S; He Q; Du Y; Tian Z; Gao X; Ma K; Fang Y; Li C; Zhao J; Wang X; Ji Q Genome Med; 2021 Aug; 13(1):125. PubMed ID: 34365978 [TBL] [Abstract][Full Text] [Related]
5. Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice. Li CN; Wang X; Lei L; Liu MZ; Li RC; Sun SJ; Liu SN; Huan Y; Zhou T; Liu Q; Cao H; Bai GL; Han YW; Shen ZF Phytother Res; 2020 May; 34(5):1166-1174. PubMed ID: 31833107 [TBL] [Abstract][Full Text] [Related]
6. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice. Zhang W; Xu JH; Yu T; Chen QK Biomed Pharmacother; 2019 Oct; 118():109131. PubMed ID: 31545226 [TBL] [Abstract][Full Text] [Related]
7. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota. Fang Y; Zhang J; Zhu S; He M; Ma S; Jia Q; Sun Q; Song L; Wang Y; Duan L Pharmacol Res; 2021 Mar; 165():105439. PubMed ID: 33493658 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of bifidobacteria and berberine in people with hyperglycemia: study protocol for a randomized controlled trial. Ming J; Xu S; Liu C; Liu X; Jia A; Ji Q Trials; 2018 Jan; 19(1):72. PubMed ID: 29373989 [TBL] [Abstract][Full Text] [Related]
9. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways. Dou Y; Huang R; Li Q; Liu Y; Li Y; Chen H; Ai G; Xie J; Zeng H; Chen J; Luo C; Su Z Biomed Pharmacother; 2021 May; 137():111312. PubMed ID: 33524788 [TBL] [Abstract][Full Text] [Related]
10. In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications. Di S; Han L; An X; Kong R; Gao Z; Yang Y; Wang X; Zhang P; Ding Q; Wu H; Wang H; Zhao L; Tong X J Ethnopharmacol; 2021 Aug; 276():114180. PubMed ID: 33957209 [TBL] [Abstract][Full Text] [Related]
11. Suppression of Berberine and Probiotics ( Huang C; Sun Y; Liao SR; Chen ZX; Lin HF; Shen WZ Front Microbiol; 2022; 13():869931. PubMed ID: 35572672 [TBL] [Abstract][Full Text] [Related]
12. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628 [TBL] [Abstract][Full Text] [Related]
13. Modulating gut microbiota as an anti-diabetic mechanism of berberine. Han J; Lin H; Huang W Med Sci Monit; 2011 Jul; 17(7):RA164-7. PubMed ID: 21709646 [TBL] [Abstract][Full Text] [Related]
14. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084 [TBL] [Abstract][Full Text] [Related]
15. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. Yue SJ; Liu J; Wang AT; Meng XT; Yang ZR; Peng C; Guan HS; Wang CY; Yan D Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E73-E85. PubMed ID: 30422704 [TBL] [Abstract][Full Text] [Related]
16. Effects of Berberine Plus Inulin on Diabetes Care in Patients With Latent Autoimmune Diabetes in Adults: Protocol for a Randomized Controlled Trial. Zhang R; Xiao Y; Yan J; Yang W; Wu X; Mei Z; Zhou Z Front Endocrinol (Lausanne); 2022; 13():876657. PubMed ID: 35784546 [TBL] [Abstract][Full Text] [Related]
17. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947 [TBL] [Abstract][Full Text] [Related]
18. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota. Chen H; Zhang F; Li R; Liu Y; Wang X; Zhang X; Xu C; Li Y; Guo Y; Yao Q Biomed Pharmacother; 2020 Apr; 124():109829. PubMed ID: 31958765 [TBL] [Abstract][Full Text] [Related]
19. Exploring the synergistic and complementary effects of berberine and paeoniflorin in the treatment of type 2 diabetes mellitus by network pharmacology. Zhang L; Han L; Ma J; Wu T; Wei Y; Zhao L; Tong X Eur J Pharmacol; 2022 Mar; 919():174769. PubMed ID: 35151646 [TBL] [Abstract][Full Text] [Related]
20. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis. Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q Front Immunol; 2020; 11():588079. PubMed ID: 33072135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]